↓ Skip to main content

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Overview of attention for article published in Journal of Clinical Oncology, May 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
3 news outlets
blogs
3 blogs
twitter
7 X users

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 9 14%
Student > Postgraduate 4 6%
Student > Bachelor 3 5%
Professor 2 3%
Other 1 2%
Other 3 5%
Unknown 44 67%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 9%
Medicine and Dentistry 6 9%
Immunology and Microbiology 4 6%
Agricultural and Biological Sciences 2 3%
Nursing and Health Professions 1 2%
Other 1 2%
Unknown 46 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2024.
All research outputs
#1,310,439
of 34,161,505 outputs
Outputs from Journal of Clinical Oncology
#3,532
of 32,213 outputs
Outputs of similar age
#18,205
of 364,626 outputs
Outputs of similar age from Journal of Clinical Oncology
#79
of 1,001 outputs
Altmetric has tracked 34,161,505 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,213 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.1. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,626 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 1,001 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.